基本信息
views: 9
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Dr. Laura Giovati, graduated in Agro-Industrial Biotechnology (110/110) at the University of Verona, discussing an experimental thesis developed at the Department of Applied Chemistry and Microbiology, of the Helsinki University (Erasmus exchange program). From 2006 to 2009, she attended a PhD Program at the Department of Pathology and Laboratory Medicine of the University of Parma, earning the PhD in Microbiology and Virology.
From 2010 to 2012 she was awarded by a Post-doctoral Research Fellowships at the Microbiology Section of the Department of Pathology and Laboratory Medicine, University of Parma.
From 2012 to 2014 she was awarded by a Post-doctoral Research Fellowships at the Microbiology and Virology Unit of the Department of Biological, Biotechnological and Translational Sciences, University of Parma.
From 2014 to 2022 she was Assistant Professor (art. 24 c.3-a L. 240/10) at the Department of Medicine and Surgery, University of Parma, academic discipline MED/07 (Microbiology and Clinical Microbiology).
From 2022 she is Associate Professor at the Department of Medicine and Surgery, University of Parma, academic discipline MED/07 (Microbiology and Clinical Microbiology).
Teaching activities of Laura Giovati include lecturing in Microbiology and Clinical Microbiology in various degree courses of the University of Parma, as well as tutoring and supervising of both undergraduating and graduated students during their academic and research activities. She is a member of the teacher board for the Research Doctorate in Molecular Medicine at the same University.
Research activities of Laura Giovati have been initially focused on mycotoxins and immunoprophylactic approaches against mycotoxicosis (Polonelli et al., PLoS 2011; Giovati et al., PLoS 2014; Giovati et al., Toxins 2015). At the same time she started the collaboration for studies aimed at the structural characterization and evaluation of antimicrobial, antiviral, and immunomodulatory properties of synthetic peptides derived from the sequences of human serum proteins, in particular of antibodies (Magliani et al., Future Microbiol 2015, Ciociola et al., AAC 2016; Polonelli et al., SciRep 2016; Polonelli et al., SciRep 2017). More recent studies are dealing with the development of novel strategies for integrated biological control and novel drugs development for treatment of vector-borne diseases using toxin-producing yeasts (killer yeasts) (Martin et al., Med Vet Entomol 2016; Giovati et al., Toxins 2018) and peptides derived therefrom (Magliani et al., Fut Med Chem 2011; Polonelli et al., Antonie van Leeuwenhoek 2011) or RNA interference.
Research Interests
Papers共 45 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Antibioticsno. 8 (2024): 683
Antibiotics (Basel, Switzerland)no. 3 (2023): 472-472
Journal of fungi (Basel, Switzerland)no. 2 (2021): 129
Load More
Author Statistics
#Papers: 43
#Citation: 665
H-Index: 16
G-Index: 24
Sociability: 5
Diversity: 0
Activity: 0
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn